Presentation on theme: "CNS depressants I- Sedative hypnotics"— Presentation transcript:
1CNS depressants I- Sedative hypnotics CNS depressants can be classified into:I- Sedative hypnotics II- Anxiolytic drugsIII- CNS depressants with skeletal muscle relaxant propertiesIV- Anticonvulsants V- AntipsychoticsI- Sedative hypnotics- Can be used to overcome insomnia (restlessness)- Cause drowsiness, initiation and/or maintenance of sleep- Pharmacological effects are dose related:Dose: ↑ Sedation ► Hypnosis ► Surgical anesthesia- No common structural features, include:1- Barbiturates Chloral Ureides Piperidinediones.5- Cyclopyrrolones Imidazopyridines Benzodiazepines8- Melatonin Receptor Agonist Antihistamines
21- BarbituratesThe barbiturates are 5,5-disubstituted barbituric acids.For good hypnotic activity, barbituric acid derivatives must be weak acids .They must have lipid/water partition coefficient between certain limit.The acidity of the barbiturates in aqueous solution depends on thenumber of substituents attached to barbituric acid.
3Enhance the GABA-ergic inhibitory response (as Benzodiazepines). S.E. MOA:Enhance the GABA-ergic inhibitory response (as Benzodiazepines).S.E.Slowly eliminated barbiturates: hangover (overshadow) & psychomotor impairment (injury).Now barbiturates get minimal use as sedatives & hypnotics (Why?)They have higher toxicity, that cause greater CNS depression.They induce many of the liver metabolizing enzymes.Barbiturates cause tolerance and, often physical dependence.N.B.:When an individual addicted to barbiturates, sudden withdrawal should beavoided, because it can cause grand mal seizures, which lead to a spasmof the respiratory musculature, producing impaired respiration, cyanosis,and possibly death.T
45,5,-disubstituted & 1,5,5-trisubstituted are active SAR:All other substitution ► inactive1,3-disubstituted or 1,3,5,5-tetrasubstituted are inactive or produce convulsions* Replacement of C-2 O by S → ↑ lipid solubility. Thiopental used as IV anesthetics due to rapid onset & quick brain levels achieved.* Introduction of more sulfur atoms (2,4-dithio derivatives) destroys potency, due to decreased hydrophilic character beyond required limits.
5Both substituents shoud be between 6-10 carbon. 5,5-Disubstitution:Both substituents shoud be between 6-10 carbon.Branching, unsaturation, replacement of alkyl with alicyclic or aromatic substituents, ↑ the lipid solubility leading to high potency.Introduction of a halogen atom into the 5-alkyl substituent ↑ the potency.Introduction of polar groups e.g. OH, NH2, RNH, CO, COOH and SO3H into the 5-alkyl substituent ↓ the lipid solubility (may destroy potency).For hypnotic activity, the compound must be a weak acid with suitable log P.Substitution on nitrogen:Substitution on one NH by alkyl gp ↑ lipid solubility►quicker onset & shorter durationAs the N-alkyl increases in size, the lipid solubility increases, But larger alkyl groups (> methyl) ► convulsant properties.Alkyl substitution on both N1 & N3 renders the drug nonacidic (inactive).
6Daytime Sedatives and Typical Anticonvulsants ClassificationBarbiturates are classified according to their duration of action into:Long duration of action (> 6 hours).Intermediate duration of action (3-6 hours).Short duration of action (< 3 hours).Ultrashort duration of action (intravenous anesthetics).Onset up to 1 hour lasts about 12 hours used for ; daytime sedation seldom used. - treatment of seizure disordersLong-Acting BarbituratesMephobarbital metabolically N-dealkylated to phenobarbitalslow onset (30-60 min), relatively long duration (10-16h)relatively low lipophilicity and low plasma protein binding (<40%)Daytime Sedatives and Typical Anticonvulsants
7Sedatives and Hypnotics Typical Sedatives and Hypnotics used for : - insomnia. - preoperative sedation. - Anesthesia and euthanasia in animalsSedatives and Hypnoticsused for - preoperative sedation. - insomnia (seldom used).Typical Sedatives and HypnoticsD. Ultra-Short-Acting Barbituratesthiocarbonyl and C-5 side chain with 5 carbon unit(ethyl or allyl e.g. Thiamylal CH2CH=CH2)Induction AnaesthesiaThiopental
8Barbiturate Abuse: Synthesis of Barbiturates Prolonged use leads to habituation, (tolerance to increased doses and physical dependence).Monooxygenase enzyme synthesis is increased by repeated dose of phenobarbital (enzyme induction), therefore the drug will be rapidly metabolized leading to tolerance.
9Barbiturates - Metabolism An ultimate (Ω) or penultimate (Ω-1) oxidation of C-5 substituentsOxidation of substituent at C- 5by CYP450’sMost BarbituratesBarbiturates lose their activities through metabolic transformation in the liver. In the course of metabolism the lipophilic character decreases which will diminish the concentration of the barbiturates in the cerebral tissues with loss in depressant activity.Aromatic HydroxylationPhenobarbitalMephobarbitalGlucuronide andsulfate conjugatesSlide 6
10Barbiturates - Metabolism DesulfurationThiobarbituratesN-MethylbarbituratesN-DealkylationSlide 7Desulfuration of 2-thiobarbiturates to yield more hydrophilic barbituratesN-demethylation does not proceed rapidly and excreted slowly therefore the produced metabolite accumulates with the N-alkylated barbiturates.During the course of mephobarbital therapy a definite blood level of phenobarbital has been establishedmephobarbitalphenobarbital
11Barbiturates - Metabolism N-oxidationMost BarbituratesHydrolytic cleavage of the ring leads to the formation of acetamide or dialkylacetylureaHydrolysisMost Barbiturateshepatic metabolic inactivationSlide 5
122- Chloral (Chloral hydrate) Trichloroacetaldehyde monohydrateHas no analgesic or tranquilizing effect & devoid of adverse respiratory effectsA weak acid (electron-withdrawing CCl3 group) ► irritating to stomach.MOA: Trichloroethanol has barbiturate-like effects on the GABAA receptor.Metabolism: 1. Quickly reduced to trichloroethanol (hypnotic activity).2. Quickly detoxified to the inactive trichloroacetic acid.Init. effectInactive metaboliteProlonged effect
133- Ureides 4- Piperidinediones 5- Cyclopyrrolones Only Acetylcarbromal (1-Acetyl-3-(2-Bromo-2-ethyl-butyryl)-urea ) is still available.Prolonged use is not recommended due toin vivo release of bromide ions (bromism)4- Piperidinedionese. g. Methyprylon 3,3-diethyl-5-methyl-2,4- piperidinedioneThey are effective sedative-hypnotics, structurally related tobarbiturates (Hence, many biological respects).5- Cyclopyrrolonese. g. ZopicloneA new hypnotic agent with no withdrawal symptoms(no accumulation on repeated administration).Metabolism:Major: less active, zopiclone N-oxide Minor: inactive, N-desmethylzopiclone
146- Imidazopyridinese. g. Zolpidemshort t1/2 (rapid metabolic oxidation to inactive COOH acid metabolites.Nonbenzodiazepine GABAA Agonists: [Z drugs] zopiclone & zolpidemAdvantages:They are used as short-acting sedative-hypnotics.They have high-affinity for GABAA receptors ~ to benzodiazepines.They are highly lipophilic, so rapid absorption & distribution.They have very little physical dependence & abuse potential.
157- Benzodiazepines Advantages: Over Barbiturates: Disadvantages: MOA: bind to specific binding sites in GABAA receptors.Used as anxiolytics, hypnotics, anticonvulsants and muscle relaxants.Advantages: Over Barbiturates:Relative safety (no respiratory depression). Preferred for patients with suicidal intentions. Fewer drug interactions.Disadvantages:Slowly eliminated due to active metabolites in blood and brain (hangover effect and accumulation on repeated dose).
168- Melatonin Receptor Agonist MT receptor play important role in discovery and approval of ramelteon.RamelteonIt is effective in initiating sleep (shortening sleep latency) but not in maintaining sleep (has short half-life).It is a very potent & very selective ligand for the MT1 receptorused in the treatment of insomnia.Does not bind with other receptors associated with sleep (GABAA or dopamine).